Structure-Activity Study of Vitamin D Analogues
Structure-Activity Study of Vitamin D Analogues
批准号:
09672266
负责人:
OKANO Toshio
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
To clarify the structure-function relationship of vitamin D analogues我们联合novel vitamin D analogues and evaluated their biological activities.(1) A系列singly dehydroxylated 19-no -1α,25-dihydroxyvitamin D - 23 D2 A-ring analogues were synthesized. The analogues could be clearlydivided into two categoriesone group, bearing 1α-hydroxy or 3β-hydroxy group in the A-ringwere potent differentiators and the second group, bearing 1β-hydroxy or 3α-hydroxy group,apoptosis potent stimulators of apoptosis.这些findings will provide useful information only fordevelopment of therapeutic agents for treatment of leukemia and其他cancers.(2) Biologicalactivities of a series of 2β-substituted analogues of 1α,25(OH) y D22 y D2)D y D23 y D2 were evaluated. Binding affinity for VDR,transactivation potency on the target gene and VDR-mediated gene regulation of the hydroxyalkyl andhydroxyalkoxy 2β-substituted analogues almost comparable to those of 1α,25(OH) D22 (OH) d2…2, while the alkyl and alkenyl analogues were much less active than 1α,25(OH) i D22 i D2 i D23 i D2. Furthermore,我们发现了一个promising candidate for preventive and therapeutic medicine of osteoporosis among thesecompounds.(3) The biological activity of two sets of ring A stereo isomers of 2-methyl-1α,25-dihydroxyvitamin D - 23 D2 and 2-methyl-20-epi-1α,25-dihydroxyvitamin D - 23 D -2 were evaluated. We found that 2β-methyl-20-epi-3-epi-1β,25(OH) - D22 - D2 - D23 - D2 is transcriptionally more active than 1α,25(OH) - D22 - D2 - D23 - D2 despite lacking the 1α-hydroxyl group,关于VDR-mediated gene transcription.自C-20natural counterpart, 2β-methyl-3-epi-1β, 25(OH) - D22 - D2D - D23 - D2,was almost completely biologically inactive20 . epimerization是很可能的反应,为基因表达式的活动。(4)我们发现了绑定affinity 1α, 25(OH) i - D22 i - D22 i - D2 and 1α,25(OH) i - D22 i - D2D i - D24 i - D2 were almost comparable to the effects of 1α, 25(OH) i - D22 i - D2D i - D23 i - D2while 24-epi-1α, 25(OH) - D22 - D22 - D2 and 1α,25(OH) i D22 i D2D i D27 i D2 were much less active than 1α,25(OH) - D22 - D2 - D23 - D2 in these respects. This is the first finding concerning biologicalassessment of 1α, 25(OH) i - D22 i - D22 i - D2, 1α, 25(OH) i - D22 i - D2D i - D23 i - D2, 1α,25(OH) - D22 - D2 - D24 -epi-1α, 25(OH) - D22 - D2 - D22 - D2 and 1α,25(OH) - D22 - D2 - D27 - D2 at the molecular level,especially with regards to the structural differences at the 24r - or 24s -methyl group and a doublebond between carbons 22 and 23 in the side chain of 1α,2 .(5) The effects of 1α,25(OH) - D22 - D2D - D23 - D2 and its analogues on transmembrane Ca - D12+ - D1 influx were examined inthe growth phase of rat osteosarcoma ROS17/2.8 cells.The results suggest that 1α,25(OH) - D22 - D2D - D23 - D2 and its analogues modulate transmembrane Ca - D12+ - D1 influx inosteoblast-like cells by opening L-type Ca D12+ D1 channels which can recognize 1α-hydroxy(6)我们demonstrated that 1α, 1β-hydroxy analogues as antagonists.25(OH) - D22 - D2-mediated suppressive effects on the inducible expression of cytokine genesin human T cells may, in part,be due to diminished activity of the transcription factor NFAT. the vitamin D - 23 - D2 receptor(VDR) specifically bound to the distal NFAT site in the human IL-2 promoter. Less
英文摘要
To clarify the structure-function relationship of vitamin D analogues, we synthesized novel vitamin D analogues and evaluated their biological activities.(1) A series of singly dehydroxylated 19-nor-1α, 25-dihydroxyvitamin DィイD23ィエD2 A-ring analogues were synthesized. The analogues could be clearly divided into two categories ; one group, bearing 1α-hydroxy or 3β-hydroxy groups in the A-ring, were potent differentiators and the second group, bearing 1β-hydroxy or 3α-hydroxy groups, were potent stimulators of apoptosis. These findings will provide useful information not only for development of therapeutic agents for treatment of leukemia and other cancers.(2) Biological activities of a series of 2β-substituted analogues of 1α, 25(OH)ィイD22ィエD2)DィイD23ィエD2 were evaluated. Binding affinity for VDR, transactivation potency on the target gene and VDR-mediated gene regulation of the hydroxyalkyl and hydroxyalkoxy 2β-substituted analogues were almost comparable to those of 1α, 25(OH)ィイD22ィエD2Dィ … More イD23ィエD2, while the alkyl and alkenyl analogues were much less active than 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2. Furthermore, we found a promising candidate for preventive and therapeutic medicine of osteoporosis among these compounds.(3) The biological activity of two sets of ring A stereo isomers of 2-methyl-1α, 25-dihydroxyvitamin DィイD23ィエD2 and 2-methyl-20-epi-1α, 25-dihydroxyvitamin DィイD23ィエD2 were evaluated. We found that 2β-methyl-20-epi-3-epi-1β, 25(OH)ィイD22ィエD2DィイD23ィエD2 is transcriptionally more active than 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2 despite lacking the 1α-hydroxyl group, which was believed to be essential for expressing VDR-mediated gene transcription. Since the C-20 natural counterpart, 2β-methyl-3-epi-1β, 25(OH)ィイD22ィエD2DィイD23ィエD2, was almost completely biologically inactive, 20-epimerization is probably responsible for activation of gene expression.(4) We found that binding affinity 1α, 25(OH)ィイD22ィエD2DィイD22ィエD2 and 1α, 25(OH)ィイD22ィエD2DィイD24ィエD2 were almost comparable to the effects of 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2, while 24-epi-1α, 25(OH)ィイD22ィエD2DィイD22ィエD2 and 1α, 25(OH)ィイD22ィエD2DィイD27ィエD2 were much less active than 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2 in these respects. This is the first finding concerning biological assessment of 1α, 25(OH)ィイD22ィエD2DィイD22ィエD2, 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2, 1α, 25(OH)ィイD22ィエD2DィイD24ィエD2, 24-epi-1α, 25(OH)ィイD22ィエD2DィイD22ィエD2 and 1α, 25(OH)ィイD22ィエD2DィイD27ィエD2 at the molecular level, especially with regards to the structural differences at the 24R- or 24S-methyl group and a double bond between carbons 22 and 23 in the side chain of 1α, 25(OH)ィイD22ィエD2D derivatives.(5) The effects of 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2 and its analogues on transmembrane CaィイD12+ィエD1 influx were examined in the growth phase of rat osteosarcoma ROS17/2.8 cells.The results suggest that 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2 and its analogues modulate transmembrane CaィイD12+ィエD1 influx in osteoblast-like cells by opening L-type CaィイD12+ィエD1 channels which can recognize 1α-hydroxy analogues as agonists and 1β-hydroxy analogues as antagonists.(6) We demonstrated that 1α, 25(OH)ィイD22ィエD2DィイD23ィエD2-mediated suppressive effects on the inducible expression of cytokine genes in human T cells may, in part, be due to diminished activity of the transcription factor NFAT. The vitamin DィイD23ィエD2 receptor (VDR) specifically bound to the distal NFAT site in the human IL-2 promoter. Less
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Fujishima T. et al.: "Efficient Synthesis and Biological Evaluation of All A-Ring Diastereomers of 1α, 25-dihydroxyvitamin D_3 and its 20-Epimer"Bioog. Med. Chem.. 8. 123-134 (2000)
Fujishima T.等人:“1α,25-二羟基维生素D_3及其20-差向异构体的所有A环非对映异构体的有效合成和生物学评价”Bioog. 8. 123-134 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsugawa N.: "Biological Activity Profiles of 1α,25-D hydroxyvitamin D2,D3,D4 D7,and 24-Epi-1α,25-dihydroxyvitamin D2" Biol.Pharm.Bull.in Press. (1999)
Tsukawa N.:“1α,25-D 羟基维生素 D2、D3、D4 D7 和 24-Epi-1α,25-二羟基维生素 D2 的生物活性概况”Biol.Pharm.Bull.in Press(1999 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okano T.: "Singly Dehydroxylated A-ring Analogues of 19-Nor-1α,25-dihydroxyvitamin D3 and 19-Nor-22-oxa-1α,25-dihydroxyvitamin D3:Novel Vitamin D3 Analogues with Potent Transcriptional Activity but Extremely Low Affinitv for Vitamin D Receptor" Biol.Pharm
Okano T.:“19-Nor-1α,25-二羟基维生素 D3 和 19-Nor-22-oxa-1α,25-二羟基维生素 D3 的单脱羟基 A 环类似物:具有有效转录活性但亲和力极低的新型维生素 D3 类似物维生素 D 受体”Biol.Pharm
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeuchi A.: "Nuclear Factor of Activated T Cells (NFAT) as a Molecular Target for 1α, 25-Dihydroxyvitamin D3-mediated Effects" J.Immunol.160. 209-218 (1998)
Takeuchi A.:“活化 T 细胞核因子 (NFAT) 作为 1α, 25-二羟基维生素 D3 介导效应的分子靶标”J.Immunol.160 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsugawa N.: "In vitro biological activities of a series of 2β-substituted analogues of 1α,25-dihydroxyvitamin D^3."Biol.Pharm.Bull.. 23(1). 66-71 (2000)
Tsukawa N.:“1α,25-二羟基维生素 D^3 的一系列 2β 取代类似物的体外生物活性。”Biol.Pharm.Bull.. 23(1) (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 53 条
Construction of an arteriosclerosis assessment system using genetically modified cells and animals, and drug development
-
批准号:20590078
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:OKANO Toshio
-
依托单位:
Construction of gene targeting animal models for evaluating preventive and therapeutic anti-cancer effectiveness of active vitamin D analogues
-
批准号:18590089
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:OKANO Toshio
-
依托单位:
Elucidation of the mechanism of cancer cell metastasis and permeation using active vitamin D as a molecular base and development of therapeutic agents
-
批准号:15590083
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2003
-
负责人:OKANO Toshio
-
依托单位:
DEVELOPMENT OF VITAMIN D ANALOGS POSSESSING STRUCTURAL SELECTIVE REGULATORY ACTIVITY TOWARDS CANCER CELL DIFFERENTIATION AND APOPTOSIS
-
批准号:12672139
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2000
-
负责人:OKANO Toshio
-
依托单位:
国内基金
海外基金
新型滤波器综合技术-直接综合技术(Direct synthesis Technique)的研究及应用
-
批准号:61671111
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:肖飞
-
依托单位: